NCT03037073View on ClinicalTrials.gov

Duloxetine for Succinylcholine-induced Postoperative Myalgia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 15, 2017

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Postoperative Myalgia
Interventions
DRUG

Duloxetine

35 patients will receive duloxetine (Cymbalta; Eli Lilly \& Company, Indiana, USA) 30 mg orally with sips of water, 2 h before induction of anesthesia.

DRUG

Placebo oral capsule

35 patients will receive similar-looking placebo capsules (starch capsules) orally with sips of water, 2 h before induction of anesthesia.

Trial Locations (1)

71515

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03037073 - Duloxetine for Succinylcholine-induced Postoperative Myalgia | Biotech Hunter | Biotech Hunter